Share on LinkedInShare on LinkedIn

ARTICLE · 26 MARCH 2021

FDA Is Still Keeping Up With The Kardashians

Kelley Drye & Warren LLP
Kelley Drye & Warren LLP
Contributor
Kelley Drye & Warren LLP

Kelley Drye & Warren LLP

About Kelley Drye We’re focused—in key areas of the law and on the nuances of each matter—to help...

View firm profile
Explore more from Kelley Drye & Warren LLP

When it comes to the legal side of working with influencers, smart companies focus on ensuring that influencers clearly disclose that they are working with the company.

United StatesMedia, Telecoms, IT, Entertainment

When it comes to the legal side of working with influencers, smart companies focus on ensuring that influencers clearly disclose that they are working with the company. After all, that's where regulators have focused most of their attention in recent years. But that's not where a company's obligations stop – companies also need to take steps to ensure that influencers comply with other laws.

In 2015, we noted that the FDA took issue with a social media post in which Kim Kardashian praised a morning sickness drug. Although Kim did disclose that she was working with the drug company, the FDA alleged she failed to comply with prescription drug advertising requirements because she didn't disclose the "consequences that may result from the use of the drug as recommended."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from